Implementing robust amyloid PET quantification in multi‐center studies: AMYPAD approach to address data acquisition, processing, interpretation and data sharing challenges

Abstract INTRODUCTION Amyloid‐positron emission tomography (PET) is pivotal to Alzheimer's management, with the Centiloid standardizing measurements across tracers. AMYPAD trials (Diagnostic and Patient Management Study [DPMS] and Prognostic and Natural History Study [PNHS]) aimed to validate robust...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Ariane Bollack, Mahnaz Shekari, Lyduine E. Collij, Emma Luckett, David Valléz García, Pawel Markiewicz, Robin Wolz, Maqsood Yaqub, Alle Meije Wink, Rossella Gismondi, Andrew Stephens, Pieter Jelle Visser, Anja Mett, Alexander Drzezga, Christopher Buckley, Juan Domingo Gispert, Gill Farrar, Frederik Barkhof
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wiley 2025-10-01
Edice:	Alzheimer’s & Dementia: Translational Research & Clinical Interventions
Témata:	Alzheimer's amyloid Centiloid PET quantification
On-line přístup:	https://doi.org/10.1002/trc2.70190
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!